Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

cutaneous systemic sclerosis. This multicenter, randomized, double-blind study included 43 patients with systemic sclerosis of <18 months' duration. In total, 10 patients received CAT-192 10 mg/kg ...

New research has uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often ...

Hole, says that his lungs are so weak that he has to have chemotherapy and cancer tablets, despite not having any form of ...

digestive and cutaneous diseases. These relatively new agents are being used for a rapidly expanding number of systemic autoimmune diseases, including SSc—although they are not yet approved in ...

Scleroderma symptoms may be localized, primarily affecting the skin and underlying tissues. It may also be systemic, affecting your skin as well as the blood vessels and tissues of major organ ...

She has severe fatigue, arthralgias, and tight, itchy skin on her face ... a nearby university medical department who diagnoses systemic sclerosis. She and her husband are frightened, especially ...

Substantial evidence exists that patients with scleroderma have immune dysfunction and autoimmunity, and several studies support the use of immunosuppressive treatment in these patients.

New research recommends that clinicians screen for foot peripheral sensory neuropathy during initial assessments for patients with systemic sclerosis.

Adds to Extensive Preclinical and Early Clinical Evidence that Nebokitug Interferes with Key Features of Systemic SclerosisTEL AVIV, Israel, ...

Gastroesophageal reflux disease (GERD) is associated with more severe interstitial lung disease (ILD) in systemic sclerosis (SSc), according to study findings published in Rheumatology.